| 0 |
PLASMA PROTEIN METABOLISM DISORDER |
1 |
0.0323 |
| 1 |
INJECTION SITE JOINT SWELLING |
1 |
0.0179 |
| 2 |
DRUG LABEL CONFUSION |
1 |
0.0040 |
| 3 |
THERAPEUTIC PRODUCT CONTAMINATION |
1 |
0.0039 |
| 4 |
NEONATAL RESPIRATORY DEPRESSION |
1 |
0.0030 |
| 5 |
EATING DISORDER SYMPTOM |
1 |
0.0022 |
| 6 |
INJECTION SITE OEDEMA |
3 |
0.0017 |
| 7 |
REACTION TO PRESERVATIVES |
1 |
0.0012 |
| 8 |
APGAR SCORE LOW |
1 |
0.0008 |
| 9 |
HYPOTONIA NEONATAL |
1 |
0.0006 |
| 10 |
FIXED ERUPTION |
1 |
0.0006 |
| 11 |
SKIN DISCOMFORT |
1 |
0.0004 |
| 12 |
LYME DISEASE |
1 |
0.0003 |
| 13 |
TENDERNESS |
3 |
0.0003 |
| 14 |
HYPERAMMONAEMIA |
1 |
0.0002 |
| 15 |
POLYARTHRITIS |
1 |
0.0002 |
| 16 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 17 |
SKIN WARM |
1 |
0.0002 |
| 18 |
FURUNCLE |
1 |
0.0001 |
| 19 |
HAEMODIALYSIS |
1 |
0.0001 |
| 20 |
INJECTION SITE SWELLING |
9 |
0.0001 |
| 21 |
INJECTION SITE ERYTHEMA |
13 |
0.0001 |
| 22 |
EYE DISCHARGE |
1 |
0.0001 |
| 23 |
SCRATCH |
1 |
0.0001 |
| 24 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 25 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 26 |
INJECTION SITE INDURATION |
1 |
0.0001 |
| 27 |
THERAPY NON-RESPONDER |
3 |
0.0001 |
| 28 |
ULCER |
1 |
0.0001 |
| 29 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 30 |
SWELLING |
5 |
0.0001 |
| 31 |
DYSTONIA |
1 |
0.0001 |
| 32 |
PSORIATIC ARTHROPATHY |
2 |
0.0000 |
| 33 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 34 |
EATING DISORDER |
1 |
0.0000 |
| 35 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 36 |
FIBROMYALGIA |
1 |
0.0000 |
| 37 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 38 |
PAIN OF SKIN |
1 |
0.0000 |
| 39 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 40 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 41 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 42 |
ERYTHEMA |
7 |
0.0000 |
| 43 |
PREMATURE BABY |
1 |
0.0000 |
| 44 |
SUICIDE ATTEMPT |
2 |
0.0000 |
| 45 |
INJECTION SITE PAIN |
10 |
0.0000 |
| 46 |
INJECTION SITE MASS |
1 |
0.0000 |
| 47 |
PSORIASIS |
3 |
0.0000 |
| 48 |
MATERNAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 49 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 50 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 51 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 52 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 53 |
EYE IRRITATION |
1 |
0.0000 |
| 54 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 55 |
DISCOMFORT |
1 |
0.0000 |
| 56 |
SLEEP DISORDER |
1 |
0.0000 |
| 57 |
INFECTION |
2 |
0.0000 |
| 58 |
AGITATION |
1 |
0.0000 |
| 59 |
PRODUCT DOSE OMISSION ISSUE |
4 |
0.0000 |
| 60 |
PAIN IN EXTREMITY |
4 |
0.0000 |
| 61 |
HOSPITALISATION |
2 |
0.0000 |
| 62 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 63 |
ARTHRALGIA |
5 |
0.0000 |
| 64 |
ADVERSE EVENT |
1 |
0.0000 |
| 65 |
MIGRAINE |
1 |
0.0000 |
| 66 |
ALOPECIA |
2 |
0.0000 |
| 67 |
INFLUENZA |
1 |
0.0000 |
| 68 |
DEPRESSION |
2 |
0.0000 |
| 69 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 70 |
URTICARIA |
1 |
0.0000 |
| 71 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 72 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 73 |
MUSCLE SPASMS |
1 |
0.0000 |
| 74 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 75 |
PAIN |
3 |
0.0000 |
| 76 |
DIARRHOEA |
3 |
0.0000 |
| 77 |
RASH |
2 |
0.0000 |
| 78 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 79 |
BACK PAIN |
1 |
0.0000 |
| 80 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 81 |
FATIGUE |
3 |
0.0000 |
| 82 |
DRUG INEFFECTIVE |
5 |
0.0000 |
| 83 |
HEADACHE |
2 |
0.0000 |
| 84 |
PRURITUS |
1 |
0.0000 |
| 85 |
VOMITING |
1 |
0.0000 |
| 86 |
DIZZINESS |
1 |
0.0000 |
| 87 |
DYSPNOEA |
1 |
0.0000 |
| 88 |
NAUSEA |
1 |
0.0000 |